PicturaBio Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 15

Employees

  • Latest Deal Type
  • Series B1

  • Latest Deal Amount
  • $9.1M

  • Investors
  • 12

PicturaBio General Information

Description

Developer of a pathogen detection platform designed to provide accurate, digital imaging-based identification of infectious diseases. The company's platform uses single-molecule fluorescent microscopy and image analysis with machine learning to detect an array of pathogens, enabling doctors to quickly identify unknown infections through respiratory viruses.

Contact Information

Website
www.pictura.bio
Formerly Known As
OxDX
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Wood Centre for Innovation
  • Quarry Road
  • Oxford OX3 8SB
  • England, United Kingdom
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • Wood Centre for Innovation
  • Quarry Road
  • Oxford OX3 8SB
  • England, United Kingdom

PicturaBio Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PicturaBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC (Series B1) 23-Sep-2026 $9.1M Completed Clinical Trials - General
8. Early Stage VC 07-Jul-2025 Completed Clinical Trials - General
7. Early Stage VC 11-Oct-2023 Completed Clinical Trials - General
6. Accelerator/Incubator 24-May-2023 Completed Clinical Trials - General
5. Accelerator/Incubator 01-Jan-2023 Completed Clinical Trials - General
4. Grant 17-Oct-2022 Completed Clinical Trials - General
3. Seed Round 15-Feb-2022 Completed Clinical Trials - General
2. Accelerator/Incubator Completed Clinical Trials - General
1. University Spin-Out 20-Oct-2021 Completed Clinical Trials - General
To view PicturaBio’s complete valuation and funding history, request access »

PicturaBio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
A Ordinary
Ordinary
A Ordinary 11,848 $0.012272 $258.93 $258.93 1x $258.93 37.87%
To view PicturaBio’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

PicturaBio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PicturaBio Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
DTL Data Science Venture Capital Minority
Flu lab Impact Investing Minority
Impact Assets Impact Investing Minority
Defence and Security Accelerator Accelerator/Incubator Minority
Deeptech Labs Accelerator/Incubator Minority
You’re viewing 5 of 12 investors. Get the full list »

PicturaBio FAQs

  • When was PicturaBio founded?

    PicturaBio was founded in 2021.

  • Where is PicturaBio headquartered?

    PicturaBio is headquartered in Oxford, United Kingdom.

  • What is the size of PicturaBio?

    PicturaBio has 15 total employees.

  • What industry is PicturaBio in?

    PicturaBio’s primary industry is Diagnostic Equipment.

  • Is PicturaBio a private or public company?

    PicturaBio is a Private company.

  • What is PicturaBio’s current revenue?

    The current revenue for PicturaBio is .

  • How much funding has PicturaBio raised over time?

    PicturaBio has raised $15.4M.

  • Who are PicturaBio’s investors?

    DTL Data Science, Flu lab, Impact Assets, Defence and Security Accelerator, and Deeptech Labs are 5 of 12 investors who have invested in PicturaBio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process